Oncolytics Biotech Inc T.ONC

What have we got here?

[Azzak34]

https://www.mirror.co.uk/news/uk-news/bowel-cancer-treatment-breakthrough-scientists-30275322?int_source=amp_continue_reading&int_medium=amp&int_campaign=continue_reading_button#amp-readmore-target

[13X2413]

What we've got here is a company that gain any traction. Too many sellers for a company that's supposed to have something.  Would like to jump ship like others, but I'm down too much now. 

[13X2413]

Should read can't gain. 

[JohnnyYeg]

And exactly how many "sellers" of the 64,092,904 outstanding shares are selling? And conversely, how many are holding pat? Might give you some idea about the sentiment held by shareholders towards the company and future of Pelareorep.

[Noteable]

ONCY's pelareorep activates the interferon (IFN) signalling pathway which stimulates the innate and adaptive immune system where  gamma-delta (γδ) T cells, play a critical role in filling the gap needed for adaptive immune cells maturation, linking the innate and adaptive immunity together. The AWARE-1 study results presented at SABC 2022 on December 07, 2022 demonstrated

[Noteable]

“Pelareorep primes the tumor for checkpoint inhibition therapy by activating the interferon-gamma signaling pathway and tumor inflammation signature in early breast cancer patients - results of the AWARE-1 trial” Loghmani, Houra et al, Previously presented at the 2022 San Antonio Breast Cancer Symposium®; December 6-10, 2022 https://www.oncolyticsbiotech.com/technology/posters

[Noteable]

Loghmani's findings from the AWARE-1 clinical trial suggests that pelareorep works synergistically with Roche's PD-(1) immune checkpoint inhibitor Tecentiriq.

[Noteable]

March 31, 2022 /CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the successful completion of the three-patient safety run-in for the third-line metastatic colorectal cancer (mCRC) cohort of the phase 1/2 GOBLET study, following an independent review by the study's Data Safety Monitoring Board (DSMB).  https://www.oncolyticsbiotech.com/press

[13X2413]

Noteable.....love all your positivity. The dated info has to stop. We need fresh info. No one cares about old news which has been factored into the current share price.  What scares me is that the big players don't seem impressed about the previous news. If they were as hopeful as you, we wouldn't be floundering at this level.  We need news, not pipe dreams about buyouts!

[Noteable]

13X2413 go back from where you came.

[Noteable]

13X2413 first appeared on this messge board on May 26, 2023 and has posted junk ever since.

[westcoast1000]

Yes and our panc results of last fall indicate that synergy as well, as I understand it.